Hönemann, Jan-Niklas
Jordan, Jens
Article History
Received: 2 November 2023
Revised: 21 November 2023
Accepted: 2 December 2023
First Online: 10 January 2024
Compliance with ethical standards
:
: JNH has nothing to disclose. JJ is cofounder of Eternygen GmbH, received research support from Novo-Nordisk and served as advisor for Theravance.